125
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis

, , , , , , , , & show all
Pages 961-970 | Published online: 14 Jul 2015

References

  • VillanuevaCPiquerasMAracilCA randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleedingJ Hepatol20064556056716904224
  • AugustinSAltamiranoJGonzálezAEffectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleedingAm J Gastroenterol20111061787179521625271
  • AbraldesJGVillanuevaCBañaresRCooperative Group for Portal Hypertension and Variceal BleedingHepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapyJ Hepatol20084822923618093686
  • BoschJAbraldesJGBerzigottiAGarcia-PaganJCThe clinical use of HVPG measurements in chronic liver diseaseNat Rev Gastroenterol Hepatology20096573582
  • GroszmannRJGarcia-TsaoGBoschJPortal Hypertension Collaborative GroupBeta-blockers to prevent gastroesophageal varices in patients with cirrhosisN Engl J Med20053532254226116306522
  • BoschJGarcia-PaganJCPrevention of variceal rebleedingLancet200336195295412648985
  • D’AmicoGGarcia-PaganJCLucaABoschJHepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic reviewGastroenterology20061311611162417101332
  • Garcia-TsaoGSanyalAJGraceNDCareyWPrevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosisHepatology20074692293817879356
  • Garcia-TsaoGBoschJGroszmannRJPortal hypertension and variceal bleeding – unresolved issues. Summary of an American association for the study of liver diseases and European association for the study of the liver single-topic conferenceHepatology2008471764177218435460
  • BoschJCarvedilol for portal hypertension in patients with cirrhosisHepatology2010512214221820513005
  • TripathiDFergusonJWKocharNRandomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleedHepatology20095082583319610055
  • LoGHChenWCWangHMYuHCRandomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleedingJ Gastroenterol Hepatol2012271681168722849337
  • ShahHAAzamZRaufJCarvedilol vs esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multi-centre randomized controlled trialJ Hepatol20146075776424291366
  • HobolthLBendtsenFHansenEFMollerSEffects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised studyDig Liver Dis20144625125624290869
  • BañaresRMoitinhoEPiquerasBCarvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosisHepatology199930798310385642
  • BañaresRMoitinhoEMatillaARandomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosisHepatology2002361367137312447861
  • DeBKDasDSenSAcute and 7-day portal pressure response to carvedilol and propranolol in cirrhoticsJ Gastroenterol Hepatol20021718318911966949
  • LinHCYangYYHouMCHuangYTLeeFYLeeSDAcute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosisAm J Gastroenterol2004991953195815447755
  • HobolthLMollerSGronbaekHRoelsgaardKBendtsenFFeldager HansenECarvedilol or propranolol in portal hypertension? A randomized comparisonScand J Gastroenterol20124746747422401315
  • RenRRThe comparison of recent curative effect on the reduction of hepatic vein pressure gradient in patients with cirrhosisShandong University2012
  • QuCXThe preliminary research of the short-term reduction of hepatic vein pressure gradient to predict the long-term curative effect of beta-blockersShandong University2012
  • GluudLLBias in clinical intervention researchAm J Epidemiol200616349350116443796
  • KjaergardLLVillumsenJGluudCReported methodologic quality and discrepancies between large and small randomized trials in meta-analysesAnn Intern Med200113598298911730399
  • Garcia-TsaoGCurrent management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitisGastroenterology200112072674811179247
  • TsochatzisEATriantosCKBurroughsAKGastrointestinal bleeding: carvedilol-the best beta-blocker for primary prophylaxis?Nat Rev Gastroenterol Hepatol2009669269419946301
  • HemstreetBAEvaluation of carvedilol for the treatment of portal hypertensionPharmacotherapy2004249410414740791
  • TripathiDTherapondosGLuiHFStanleyAJHayesPCHaemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertensionAliment Pharmacol Ther20021637338011876689
  • ReibergerTUlbrichGFerlitschAVienna Hepatic Hemodynamic LabCarvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranololGut2013621634164123250049
  • SinagraEPerriconeGD’AmicoMTineFD’AmicoGSystematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosisAliment Pharmacol Ther20143955756824461301